Research Overview
The bioregulator hypothesis
The Khavinson programme began in the 1970s with peptide extracts prepared from individual animal tissues and later moved to fully synthetic di-, tri- and tetrapeptides once candidate active sequences were proposed. The central claim is that very short peptides act as tissue-specific regulatory signals, entering cells and interacting with chromatin to influence transcription. Cerluten belongs to the earlier, extract-based half of that programme.
What a natural complex means analytically
Because the material is a fractionated extract, it cannot be characterised the way a synthetic peptide can. There is no single mass, sequence or CAS entry. Instead, lot documentation describes protein and peptide content, molecular-weight distribution and the absence of specified contaminants. This has practical consequences for research design: batch-to-batch variation is inherent, and a study that spans multiple lots should record which lot generated which data.
Research context
- Comparative work against defined synthetic bioregulators such as Pinealon (EDR) and Cortagen (AEDP)
- Neuronal survival and ageing markers in tissue and cell models
- Fraction-profiling studies aimed at identifying which components carry activity
- Methodological work on characterising and standardising tissue-derived peptide preparations
Evidence limitations
Most published work on this family originates from a small group of investigators and appears predominantly in Russian-language journals, with limited independent replication and few blinded, controlled designs. Mechanistic proposals about nuclear entry and gene regulation are supported by in-vitro observations that have not been broadly reproduced. These constraints do not make the material uninteresting as a research subject, but they do mean claims about outcomes should not be inferred from the existing record.
